Clinical and Economic Outcomes Associated With Use of Liposomal Bupivacaine Versus Standard of Care for Management of Postsurgical Pain in Pediatric Patients Undergoing Spine Surgery
**Background:** Approximately 60% of hospitalized children undergoing surgery experience at least 1 day of moderate-to-severe pain after surgery. Pain following spine surgery may affect opioid exposure, length of stay (LOS), and costs in hospitalized pediatric patients. This is a retrospective cohor...
Main Authors: | Robert Tracy Ballock, John Seif, Ryan Goodwin, Jennifer H. Lin, Jessica Cirillo |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2021-04-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://jheor.scholasticahq.com/article/21967-clinical-and-economic-outcomes-associated-with-use-of-liposomal-bupivacaine-versus-standard-of-care-for-management-of-postsurgical-pain-in-pediatric-p.pdf |
Similar Items
-
Liposomal extended-release bupivacaine for postsurgical analgesia
by: Lambrechts M, et al.
Published: (2013-09-01) -
Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia
by: Candiotti KA, et al.
Published: (2012-05-01) -
Medial and Lateral Pectoral Nerve Block with Liposomal Bupivacaine for the Management of Postsurgical Pain after Submuscular Breast Augmentation
by: David Leiman, MD, et al.
Published: (2014-12-01) -
Infiltration of liposome bupivacaine into the transversus abdominis plane for postsurgical analgesia in robotic laparoscopic prostatectomy: a pilot study
by: Sternlicht A, et al.
Published: (2014-12-01) -
Chondrotoxicity of Local Anesthetics: Liposomal Bupivacaine Is Less Chondrotoxic than Standard Bupivacaine
by: Travis Farmer, et al.
Published: (2020-01-01)